Pharmaceuticals Stocks

Pharmaceuticals

LINCOPH FY2025

Lincoln Pharma

Revenue of ₹623 Cr in FY2025.

Rev ₹623 Cr +7.4% YoY +8.9% 10Y CAGR PE 15.7

Pharmaceuticals

LUPIN FY2025

Lupin

Revenue of ₹22,904 Cr in FY2025.

Rev ₹22,904 Cr +13.8% YoY +6.0% 10Y CAGR PE 32.2

Pharmaceuticals

NATCOPHARM FY2025

Natco Pharma

Revenue grew 15.9% to ₹4,784 Cr in FY2025.

Rev ₹4,784 Cr +15.9% YoY +19.2% 10Y CAGR PE 10.4

Pharmaceuticals

NATCAPSUQ FY2025

Natural Capsule

Revenue of ₹170 Cr in FY2025.

Rev ₹170 Cr +9.3% YoY +9.7% 10Y CAGR PE 699.1

Pharmaceuticals

NEULANDLAB FY2025

Neuland

Revenue of ₹1,497 Cr in FY2025.

Rev ₹1,497 Cr -4.7% YoY +12.3% 10Y CAGR PE 74.0

Pharmaceuticals

NOVARTIND FY2025

Novartis

Revenue of ₹356 Cr in FY2025.

Rev ₹356 Cr +6.3% YoY -8.6% 10Y CAGR PE 25.3

Pharmaceuticals

PFIZER FY2025

Pfizer

Revenue of ₹2,454 Cr in FY2025.

Rev ₹2,454 Cr +3.4% YoY +2.8% 10Y CAGR PE 28.1

Pharmaceuticals

PEL FY2025

Piramal Enterprises

Turned profitable with net income of ₹485 Cr in FY2025.

Rev ₹10,612 Cr +4.3% YoY +7.6% 10Y CAGR PE 52.7

Pharmaceuticals

PGHL FY2025

Procter & Gamble Health

Revenue declined 19.1% to ₹945 Cr in FY2025.

Rev ₹945 Cr -19.1% YoY +0.8% 11Y CAGR PE 36.9

Pharmaceuticals

RPGLIFE FY2025

RPG Life Sciences Limited

Revenue of ₹666 Cr in FY2025.

Rev ₹666 Cr +13.0% YoY +10.6% 10Y CAGR PE 20.7

Pharmaceuticals

SANOFI FY2024

Sanofi India

Revenue declined 30.4% to ₹2,030 Cr in FY2024.

Rev ₹2,030 Cr -30.4% YoY +0.3% 10Y CAGR PE 19.0

Pharmaceuticals

SEQUENT FY2025

Sequent Scientific

Turned profitable with net income of ₹32.3 Cr in FY2025.

Rev ₹1,551 Cr +12.4% YoY +13.3% 10Y CAGR PE 236.7

Pharmaceuticals

SHILPAMED FY2025

Shilpa Medicare

Revenue of ₹1,286 Cr in FY2025.

Rev ₹1,286 Cr +11.7% YoY +7.7% 10Y CAGR PE 101.2

Pharmaceuticals

STAR FY2025

Strides Arcolab

Turned profitable with net income of ₹3,598 Cr in FY2025.

Rev ₹4,624 Cr +13.0% YoY +14.5% 10Y CAGR PE 2.7

Pharmaceuticals

SUNPHARMA FY2025

Sun Pharma

Revenue of ₹52,578 Cr in FY2025.

Rev ₹52,578 Cr +5.5% YoY +6.7% 10Y CAGR PE 39.7

Pharmaceuticals

SUVEN FY2025

Suven Life

Revenue declined 43.1% to ₹6.66 Cr in FY2025.

Rev ₹6.66 Cr -43.1% YoY -35.3% 10Y CAGR

Pharmaceuticals

TORNTPHARM FY2025

Torrent Pharma

Revenue of ₹11,539 Cr in FY2025.

Rev ₹11,539 Cr +7.0% YoY +9.5% 10Y CAGR PE 74.1

Pharmaceuticals

WOCKPHARMA FY2025

Wockhardt

Reported a net loss of ₹57.0 Cr in FY2025.

Rev ₹3,074 Cr +6.7% YoY -3.7% 10Y CAGR